Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Immuneering (IMRX) FCF Margin (2020 - 2022)

Immuneering's FCF Margin history spans 3 years, with the latest figure at 2597344.18% for Q4 2022.

  • On a quarterly basis, FCF Margin fell 259246418.0% to 2597344.18% in Q4 2022 year-over-year; TTM through Sep 2023 was 10809489.45%, a 1080113559.0% decrease, with the full-year FY2022 number at 14148.44%, down 1266227.0% from a year prior.
  • FCF Margin came in at 2597344.18% for Q4 2022, down from 28701.08% in the prior quarter.
  • The five-year high for FCF Margin was 511.54% in Q3 2020, with the low at 2597344.18% in Q4 2022.
  • Historically, FCF Margin has averaged 265287.05% across 3 years, with a median of 3378.13% in 2021.
  • Biggest five-year swings in FCF Margin: crashed -136471bps in 2021 and later plummeted -259246418bps in 2022.
  • Year by year, FCF Margin stood at 825.64% in 2020, then plummeted by -491bps to 4880.0% in 2021, then plummeted by -53124bps to 2597344.18% in 2022.
  • Business Quant data shows FCF Margin for IMRX at 2597344.18% in Q4 2022, 28701.08% in Q3 2022, and 10182.56% in Q2 2022.